C12R 2001/21
Haemophilus
C12R2001/21 (Haemophilus) appears on 11 US grants and 13 published applications in this corpus.
Search patents in C12R- Granted patents
- 11
- Published applications
- 13
- Assignees
- 15
- Inventors
- 44
- Latest grant
- 15 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Biofixation of greenhouse gas by mass culture of Haematococcus sp. Kau-01 microalga in high efficiency medium15 Aug 2023US 11,725,219 B2King Abdulaziz University
- Biomass formation by mass culture of haematococcus sp. KAU-01 microalga in high efficiency medium10 May 2022US 11,326,186 B1King Abdulaziz University
- Mutant bacteria for production of generalized modules for membrane antigens15 Dec 2020US 10,864,262 B2Glaxosmithkline Biologicals SA
- Antigens and antigen combinations7 May 2019US 10,279,026 B2Glaxosmithkline Biologicals SA
- Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin15 Mar 2016US 9,284,526 B2Gsk Vaccines S.R.L.
- Compositions and methods for epigenetic editing19 Jun 2025US 2025/0197818 A1nChroma Bio, Inc.
- Recombinant yeasts for producing acetone and/or isopropanol from fatty acid feedstocks4 Jul 2024US 2024/0218383 A1Circular Industries Holding Pte Ltd.
- Methods, compositions, and systems for treating dental caries and a periodontal disease based on microbiome modulation through oral microbiome transplant (omt)30 May 2024US 2024/0173364 A1The Penn State Research Foundation
- Antigen binding proteins and assays14 Jul 2022US 2022/0221455 A1Glaxosmithkline Biologicals SA
- Biofixation of greenhouse gas by mass culture of haematococcus sp. kau-01 microalga in high efficiency medium9 Jun 2022US 2022/0177929 A1King Abdulaziz University
Most cited
By later US patents
- Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype21US 4,337,314 AResearch Corporation · 1982
- Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype17US 4,681,762 AResearch Corporation · 1987
- Novel polysaccharide extracts and method of use12US 4,210,641 ARoussel Uclaf · 1980
- Live attenuated RTX-producing bacteria of the family pasteurellaceae2US 6,770,275 B1Akzo Nobel N. V. · 2004
- Modified live (JMSO strain) Haemophilus parasuis vaccine2US 8,404,253 B2Newport Laboratories, Inc. · 2013